Last shipping dates of 2024 & first shipping dates of 2025
Keeping you updated with our last shipping dates for 2024 and the first shipping dates of 2025.
12
11, 2024
7
11, 2024
Qkine announces a new sales distribution agreement in Türkiye with distributor Pitagen
Qkine, a leading manufacturer of high purity bioactive proteins, is pleased to announce its new sales distribution agreement with leading Turkish cell biology and stem cell reagent supplier Pitagen.
7
11, 2024
Qkine announces a new UK & Ireland sales distribution agreement with SLS
Qkine is pleased to announce a new UK & Ireland sales distribution agreement with SLS, the largest independent supplier of laboratory equipment, chemicals, and consumables in the UK.
24
10, 2024
Qkine strengthens its support for the cellular agriculture through provision of high quality food grade growth factors
Qkine announces the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant growth factor supply chain for emerging sectors including cultivated meat, fish, fat and dairy.
24
10, 2024
National Alternative Protein Innovation Centre (NAPIC) launched
NAPIC is a £38m centre dedicated to developing acceptable and planet-friendly alternatives to animal proteins led by researchers from the University of Leeds, James Hutton Institute, University of Sheffield and Imperial College London.
23
10, 2024
Pep Talk October 2024
In this edition, we are excited to announce a price freeze moving into 2025, our win of Scale-up of the Year in the Cambridge Business Awards. We also share our latest hematopoietic stem cells blog, new products IL-2 and activin E PLUS and a new application note on growth factor stability.
23
10, 2024
Qkine announces price freeze for 2025 in support of global stem cell science
As part of our commitment to supporting our customers and their science in economically difficult times, we have decided to hold our prices into 2025.
4
10, 2024
Qkine integrates the latest advancement in fill-finish automation into its recombinant protein manufacturing process
Our latest investment in our mission at Qkine to produce the highest quality growth factors for research. The most state-of-the-art automated system which fills, labels and caps vials with minimal manual intervention.
3
10, 2024
Qkine winners of Cambridge Business Awards 2024 – Scale-up of the Year
Qkine wins 'Scale-up of the Year' at the 2024 Cambridge Independent Business Awards On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the [...]
12
09, 2024
Qkine collaboration with the Bertero Lab, Heart Engineering and Developmental Genomics et al. (HEDGe), University of Turin, Italy
This recent publication in collaboration with Qkine focusses on the optimization of home-brew media for the maintenance of human induced pluripotent stem cells (hiPSCs), using Qkine growth factors to allow cost-effective, practical, and reproducible culture of hiPSCs. Qkine thermostable tag-free FGF2-G3 proteins were found to be highly bioactive, necessitating an 8-fold reduction in concentration for the short (145 aa) form of FGF2-G3 in the optimized media.
